周达新,潘文志,吴永健,宋光远

• 1:中国医师协会心血管内科医师分会结构性心脏病专业委员会
• 2:复旦大学附属中山医院
• 3:中国医学科学院阜外医院

摘要(Abstract)：

<正>经导管主动脉瓣置换术(transcatheter aortic valvereplacement,TAVR),又称经导管主动脉瓣置入术(transcatheter aortic valve implantation,TAVI),是指将组装完备的人工主动脉瓣经导管置入到病变的主动脉瓣处,在功能上完成主动脉瓣的置换。自2002年首例成功以来[1],TAVR已成为老年主动脉瓣狭窄(aortic stenosis,AS)患者的一线治疗手段。欧美国家相继颁布并更新了TAVR的指导性文

关键词(KeyWords)： 经导管主动脉瓣置换术;经导管主动脉瓣置入术;专家共识

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 周达新,潘文志,吴永健,宋光远

参考文献(References)：

• [1]Cribier A,Eltchaninoff H,Bash A,et al.Percutaneous transcatheter implantation of an aortic valve prosthesis f or calcif ic aortic stenosis:first human case description.Circulation,2002,106(24):3006-3008.
• [2]Holmes DR,Mack MJ,Kaul S,et al.2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement.J Am Coll Cardiol,2012,59(13):1200-1254.
• [3]Nishimura RA,Otto CM,Bonow RO,et al.2014 AHA/ACCguideline for the management of patients with valvular heart disease:executive summary:a report of the American College of Cardiology/American Heart Association task force on practice guidelines.J Am Coll Cardiol,2014,63(22):2438-2488.
• [4]Baumgartner H,Falk V,Bax JJ,et al.2017 ESC/EACTS guidelines for the management of valvular heart disease.Eur Heart J,2017,38(36):2739-2791.
• [5]Nishimura RA,Otto CM,Bonow RO,et al.2017 AHA/ACCfocused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease:A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines.J Am Coll Cardiol,2017,70(2):252-289.
• [6]Otto CM,Kumbhani DJ,Alexander KP,et al.2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis:a report of the American College of Cardiology task force on clinical expert consensus documents.J Am Coll Cardiol,2017,69(10):1313-1346.
• [7]葛均波，周达新，潘文志，等.经皮主动脉瓣置入术一例报道附操作要点.中国介入心脏病杂志，2010,18(5):243-246.
• [8]中国医师协会心血管内科医师分会结构性心脏病专业委员会，中华医学会心血管病学分会结构性心脏病学组.经导管主动脉瓣置换术中国专家共识.中国介入心脏病学杂志，2015,23(12):661-667.
• [9]Otto CM,Lind BK,Kitzman DW,et al.Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.N Engl J Med,1999,341(3):142-147.
• [10]Nkomo VT,Gardin JM,Skelton TN,et al.Burden of valvular heart diseases:a population-based study.Lancet,2006,368(9540):1005-1011.
• [11]Pan W,Zhou D,Cheng L,et al.Candidates for transcatheter aortic valve implantation may be fewer in China.Int J Cardiol,2013,168(5):e133-e134.
• [12]Jilaihawi H,Wu Y,Yang Y,et al.Morphological characteristics of severe aortic stenosis in China:imaging corelab observations from the fi rst Chinese transcatheter aortic valve trial.Catheter Cardiovasc Interv,2015,85(Suppl 1):752-761.
• [13]Pan W,Zhou D,Cheng L,et al.Aortic regurgitation is more prevalent than aortic stenosis in Chinese elderly population:implications for transcatheter aortic valve replacement.Int J Cardiol,2015,201:547-548.
• [14]Li Y,Wei X,Zhao Z,et al.Prevalence and complications of bicuspid aortic valve in Chinese according to echocardiographic database.Am J Cardiol,2017,120(2):287-291.
• [15]Hu P,Liu XB,Liang J,et al.A hospital-based survey of patients with severe valvular heart disease in China.Int J Cardiol,2017,231:244-247.
• [16]潘文志，李明飞，周达新，等.重度主动脉瓣狭窄患者二叶式主动脉瓣的超声心动图分析.中华心血管病杂志，2015,43(3):244-247.
• [17]Mack MJ,Leon MB,Thourani VH,et al.Transcatheter aorticvalve replacement with a balloon-expandable valve in low-risk patients.N Engl J Med,2019,380(18):1695-1705.
• [18]Popma JJ,Deeb GM,Yakubov SJ,et al.Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.N Engl J Med,2019,380(18):1706-1715.
• [19]Liu XB,Jiang JB,Zhou QJ,et al.Evaluation of the safety and efficacy of transcatheter aortic valve implantation in patients with a severe stenotic bicuspid aortic valve in a Chinese population.JZhejiang Univ Sci B,2015,16(3):208-214.
• [20]Liao YB,Li YJ,Xiong TY,et al.Comparison of procedural,clinical and valve performance results of transcatheter aortic valve replacement in patients with bicuspid versus tricuspid aortic stenosis.Int J Cardiol,2018,254:69-74.
• [21]Zhou D,Pan W,Wang J,et al.Vita Flow?transcatheter valve system in the treatment of severe aortic stenosis:One-year results of a multicenter study.Catheter Cardiovasc Interv,2020,95(2):332-338.
• [22]宋光远，王墨扬，王媛，等.Venus-A主动脉瓣膜介入治疗重度主动脉瓣狭窄的效果.中华心血管病杂志，2017,45(10):843-847.
• [23]Liu H,Yang Y,Wang W,et al.Transapical transcatheter aortic valve replacement for aortic regurgitation with a second-generation heart valve.J Thorac Cardiovasc Surg,2018,156(1):106-116.
• [24]TchétchéD,Chevalier B,Holzhey D,et al.TAVR for failed surgical aortic bioprostheses using a self-expanding device:1-year results from the prospective VIVA postmarket study.JACCCardiovasc Interv,2019,12(10):923-932.
• [25]Yoon SH,Schmidt T,Bleiziff er S,et al.Transcatheter aortic valve replacement in pure native aortic valve regurgitation.J Am Coll Cardiol,2017,70(22):2752-2763.
• [26]中国医师协会心血管内科医师分会结构性心脏病专业委员会，中华医学会心血管病学分会结构性心脏病学组.经导管主动脉瓣置换术团队建设及运行规范中国专家建议.中国介入心脏病学杂志，2018,26(1):2-6.
• [27]Lauck SB,Sathananthan J,Park J,et al.Post-procedure protocol to facilitate next-day discharge:Results of the multidisciplinary,multimodality but minimalist TAVR study.Catheter Cardiovasc Interv,2019.[Online ahead of print]
• [28]Hosoba S,Yamamoto M,Shioda K,et al.Safety and effi cacy of minimalist approach in transfemoral transcatheter aortic valve replacement:insights from the Optimized trans Cath Eter v Alvular interventio N-Transcatheter Aortic Valve Implantation(OCEAN-TAVI)registry.Interact Cardiovasc Thorac Surg,2018,26(3):420-424.
• [29]Liu X,He Y,Zhu Q,et al.Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve.Catheter Cardiovasc Interv,2018,91(5):986-994.
• [30]Kappetein AP,Head SJ,Généreux P,et al.Updated standardized endpoint defi nitions for transcatheter aortic valve implantation:the valve academic research consortium-2 consensus document.J Am Coll Cardiol,2012,60(15):1438-1454.
• [31]Auff ret V,Puri R,Urena M,et al.Conduction disturbances after transcatheter aortic valve replacement:current status and future perspectives.Circulation,2017,136(11):1049-1069.
• [32]Siontis GC,Jüni P,Pilgrim T,et al.Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR:a Meta-analysis.J Am Coll Cardiol,2014,64(2):129-140.
• [33]Petronio AS,Sinning JM,Van Mieghem N,et al.Optimal implantation depth and adherenceto guidelines on permanent pacing to improve the results of transcatheter aortic valve replacement with the medtronic core Valve system:the Core Valve prospective,international,post-market ADVANCE-ⅡStudy.JACC Cardiovasc Interv,2015,8(6):837-846.
• [34]Rodés-Cabau J,Ellenbogen KA,Krahn AD,et al.Management of conduction disturbances associated with transcatheter aortic valve replacement:JACC Scientific Expert Panel.J Am Coll Cardiol,2019,74(8):1086-1106.
• [35]Athappan G,Patvardhan E,Tuzcu EM,et al.Incidence,predictors,and outcomes of aortic regurgitation after transcatheter aortic valve replacement:Meta-analysis and systematic review of literature.J Am Coll Cardiol,2013,61(15):1585-1595.
• [36]Pibarot P,Hahn RT,Weissman NJ,et al.Assessment of paravalvular regurgitation following TAVR:a proposal of unif ying grading scheme.JACC Cardiovasc Imaging,2015,8(3):340-360.
• [37]Ribeiro HB,Webb JG,Makkar RR,et al.Predictive factors,management,and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation:insights from a large multicenter registry.J Am Coll Cardiol,2013,62(17):1552-1562.
• [38]Lansky AJ,Brown D,Pena C,et al.Neurologic complications of unprotected transcatheter aortic valve implantation(from the NeuroTAVI Trial).Am J Cardiol,2016,118(10):1519-1526.
• [39]Davlouros PA,Mplani VC,Koniari I,et al.Transcatheter aortic valve replacement and stroke:a comprehensive review.J Geriatr Cardiol,2018,15(1):95-104.
• [40]Haussig S,Mangner N,Dwyer MG,et al.Eff ect of a cerebral protection device on brain Lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis:the CLEAN-TAVI randomized clinical trial.JAMA,2016,316(6):592-601.
• [41]Ducrocq G,Francis F,Serfaty JM,et al.Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIENprosthesis:incidence and impact on outcome.Euro Intervention,2010,5(6):666-672.
• [42]Holmes DR,Nishimura RA,Grover FL,et al.Annual outcomes with transcatheter valve therapy:from the STS/ACC TVT registry.JAm Coll Cardiol,2015,66(25):2813-2823.
• [43]Landes U,Barsheshet A,Finkelstein A,et al.Temporal trends in transcatheter aortic valve implantation,2008-2014:patient characteristics,procedural issues,and clinical outcome.Clin Cardiol,2017,40(2):82-88.
• [44]Yoon SH,Bleiziff er S,De Backer O,et al.Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis.J Am Coll Cardiol,2017,69(21):2579-2589.
• [45]Xiong TY,Feng Y,Liao YB,et al.Transcatheter aortic valve replacement in patients with non-calcifi c aortic stenosis.Euro Intervention,2018,13(15):e1756-e1763.
• [46]金沁纯，潘文志，陈莎莎，等.经导管主动脉瓣置换术治疗重度主动脉瓣狭窄的效果.中华心血管病杂志，2019,47(7):528-533.
• [47]Crowhurst JA,Savage M,Subban V,et al.Factors contributing to acute kidney injury and the impact on mortality in patients undergoing transcatheter aortic valve replacement.Heart Lung Circ,2016,25(3):282-289.
• [48]Lahoud R,Butzel DW,Parsee A,et al.Acute kidney recovery in patients who underwent transcatheter versus surgical aortic valve replacement(f rom the Northern New England Cardiovascular Disease Study Group).Am J Cardiol,2020,125(5):788-794.
• [49]Azarbal A,Leadholm KL,Ashikaga T,et al.Frequency and prognostic significance of acute kidney recovery in patients who underwent transcatheter aortic valve implantation.Am J Cardiol,2018,121(5):634-641.
• [50]Faroux L,Guimaraes L,Wintzer-Wehekind J,et al.Coronary artery disease and transcatheter aortic valve replacement:JACC state-ofthe-art review.J Am Coll Cardiol,2019,74(3):362-372.
• [51]Lateef N,Khan MS,Deo SV,et al.Meta-analysis comparing outcomes in patients undergoing transcatheter aortic valve implantation with versus without percutaneous coronary intervention.Am J Cardiol,2019,124(11):1757-1764.
• [52]Goel SS,Ige M,Tuzcu EM,et al.Severe aortic stenosis a nd coronary artery disease--implications for management in the transcatheter aortic valve replacement era:a comprehensive review.J Am Coll Cardiol,2013,62(1):1-10.
• [53]刘洋，丁鹏，程亮，等.体外膜肺氧合辅助经导管主动脉瓣植入治疗极低射血分数值的重度主动脉瓣狭窄.中国体外循环杂志，2019,17(1):13-17.